Search

Your search keyword '"Boussouar, Samia"' showing total 245 results

Search Constraints

Start Over You searched for: Author "Boussouar, Samia" Remove constraint Author: "Boussouar, Samia"
245 results on '"Boussouar, Samia"'

Search Results

3. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis.

4. Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

5. Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)

6. Strategies to safely rule out pulmonary embolism in COVID-19 outpatients: a multicenter retrospective study

7. High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study

8. Detection and severity quantification of pulmonary embolism with 3D CT data using an automated deep learning-based artificial solution

9. Detection and quantification of pulmonary embolism with artificial intelligence: The SFR 2022 artificial intelligence data challenge

10. Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

15. Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

17. Cardiac adipose tissue volume assessed by computed tomography is a specific and independent predictor of early mortality and critical illness in COVID-19 in type 2-diabetic patients

18. Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study

21. Comprehensive Characterization of Cardiac, Skeletal and Diaphragmatic Myotoxicity Using CMR in Patients with Immune Checkpoint Inhibitor Therapy and Relation to Outcomes

24. Detection and severity quantification of pulmonary embolism with 3D CT data using an automated deep learning-based artificial solution

26. Long-Term Outcome and Prognosis of Noninfectious Thoracic Aortitis

32. Kiosk 5R-TA-04 - Comprehensive Characterization of Cardiac, Skeletal and Diaphragmatic Myotoxicity Using CMR in Patients with Immune Checkpoint Inhibitor Therapy and Relation to Outcomes

33. A 24/7 Pilot Remote Emergency Multidisciplinary Discussion for Rapidly Progressive Interstitial Lung Disease: A 2-Year Experience

35. Supplementary Methods from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

36. Figure S2 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

37. Table S3 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

38. Data from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

40. One-Year Mental and Physical Health Assessment in Survivors after Extracorporeal Membrane Oxygenation for COVID-19–related Acute Respiratory Distress Syndrome

41. Cardiac Adipose Tissue Volume assessed by Computed Tomography is a specific and independent Predictor of Early Mortality and Critical Illness in COVID-19 in type 2-Diabetic Patients

45. Systemic lupus erythematosus-related acute lung disease.

46. Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults

48. COVID‐19 and its Severity in Bariatric Surgery‐Operated Patients

49. Interaction entre échocardiographie et système rénine-aldostérone comme prédicteurs de mortalité pour le COVID-19

50. Echocardiography and renin-aldosterone interplay as predictors of death in COVID-19

Catalog

Books, media, physical & digital resources